Abbott gets FDA clearance for over-the-counter continuous glucose monitors

Unlike the FreeStyle Libre systems (pictured above), Abbott’s new continuous glucose monitors won’t require a prescription. | Photo by Amelia Holowaty Krales / The Verge

Abbott announced today that the US Food and Drug Administration has cleared two new over-the-counter continuous glucose monitors (CGM). The Lingo is designed for health-conscious consumers who want to get greater insight into their metabolism. Meanwhile, the Libre Rio is designed for Type 2 diabetics who don’t rely on insulin.

CGMs ...